| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 01/16/2013 | CN102875541A Preparation method of 3-(2-benzoxazolyl)-7-hydroxy coumarin |
| 01/16/2013 | CN102875540A Weeding activity of 2-benzoxazinone-5-cyclohexylaminocarbonyltetrazolylone |
| 01/16/2013 | CN102872012A Compound capable of inhibiting protein kinase and application thereof |
| 01/16/2013 | CN101405270B Pyrazoles as 11-beta-HSD-1 |
| 01/15/2013 | US8354545 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/15/2013 | US8354531 Compounds for the treatment of inflammatory diseases |
| 01/15/2013 | US8354528 Process for making thienopyrimidine compounds |
| 01/15/2013 | US8354436 IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation |
| 01/15/2013 | US8354423 Insecticidal spironindane derivatives |
| 01/15/2013 | US8354422 Pyrimidine inhibitors of kinase activity |
| 01/15/2013 | US8354410 Compounds for the treatment of hepatitis C |
| 01/15/2013 | US8354407 2-anilino-4-(heterocyclic)amino-pyrimidines |
| 01/15/2013 | US8354405 6-cycloamino-3-(pyrid-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 01/15/2013 | US8354403 Pyrrolidine derived beta 3 adrenergic receptor agonists |
| 01/15/2013 | US8354399 Substituted indazole derivatives active as kinase inhibitors |
| 01/15/2013 | US8354398 Substituted isoxazole compounds |
| 01/15/2013 | CA2702834C Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof |
| 01/15/2013 | CA2693997C Viral polymerase inhibitors |
| 01/15/2013 | CA2547391C Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 01/15/2013 | CA2524161C Pyridinyl acetonitriles |
| 01/10/2013 | WO2013006734A1 Substituted 4-phenoxyphenol analogs as modulators of proliferating cell nuclear antigen activity |
| 01/10/2013 | WO2013006485A1 Fused benzoxazepinones as ion channel modulators |
| 01/10/2013 | WO2013006463A1 Oxazepines as ion channel modulators |
| 01/10/2013 | WO2013006308A2 Dihydropyrazoles |
| 01/10/2013 | WO2013005755A1 Methylpiperidine derivative |
| 01/10/2013 | WO2013004996A1 5- or 6 - substituted 3 - hydroxy - 2 ( 1h) - pyridinones as d-amino acid oxidase (daao) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain |
| 01/10/2013 | WO2013004332A1 Substituted azaheterocycles for the treatment of cancer |
| 01/10/2013 | WO2012141487A3 Cycloalkenyl aryl derivatives for cetp inhibitor |
| 01/10/2013 | WO2012134188A3 Novel oxazolidinone derivative and medical composition containing same |
| 01/10/2013 | WO2012123963A3 A process for preparation of iloperidone and amorphous co- precipitate of iloperidone with pharmaceutically acceptable excipient |
| 01/10/2013 | WO2012101065A3 Pyrimidine biaryl amine compounds and their use as cdk9 inhibitors |
| 01/10/2013 | WO2012061698A9 Compounds useful as modulators of trpm8 |
| 01/10/2013 | US20130012708 Heterocyclic compounds and thrombopoietin receptor activators |
| 01/10/2013 | US20130012705 Dicycloazaalkane derivatives, preparation processes and medical uses thereof |
| 01/10/2013 | US20130012704 Compounds and compositions as protein kinase inhibitors |
| 01/10/2013 | US20130012702 Purification of progesterone receptor modulators |
| 01/10/2013 | US20130012554 Oxazolidinone derivatives containing new bicyclic group, having antibacterial activity, and method for treating pathogenic bacterial infections using the same |
| 01/10/2013 | US20130012545 Amido-Thiophene Compounds and Their Use |
| 01/10/2013 | US20130012542 Injectable depot formulation comprising crystals of iloperidone |
| 01/10/2013 | US20130012541 Therapeutic Agents Useful for Treating Pain |
| 01/10/2013 | US20130012540 Hepatitis C Virus Inhibitors |
| 01/10/2013 | US20130012529 Heterobicyclic carboxamides as inhibitors for kinases |
| 01/10/2013 | US20130012526 Oxazole derivatives useful as modulators of faah |
| 01/10/2013 | US20130012514 Aminoalkyloxazole and aminoalkylthiazolecarboxylic acid amides as regeneration-promoting substances for sensory organs and post-mitotic tissue |
| 01/10/2013 | US20130012513 Hedgehog inhibitors |
| 01/10/2013 | US20130012512 P38 MAP kinase inhibitors |
| 01/10/2013 | US20130012511 Soluble guanylate cyclase activators |
| 01/10/2013 | US20130012506 Anti-infective pyrido (1,2-a) pyrimidines |
| 01/10/2013 | US20130012504 Bi-functional quinoline analogs |
| 01/10/2013 | US20130012500 Organic compounds |
| 01/10/2013 | US20130012499 Trpv4 antagonists |
| 01/10/2013 | US20130012494 Cyclopropyl-fused-1,3-thiazepines as bace1 and/or bace2 inhibitors |
| 01/10/2013 | US20130012493 Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use |
| 01/10/2013 | US20130012492 Fused heterocyclic compounds as ion channel modulators |
| 01/10/2013 | US20130012490 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
| 01/10/2013 | US20130012489 Morpholinylquinazolines |
| 01/10/2013 | US20130011927 Detection of immobilized nucleic acid |
| 01/10/2013 | US20130011361 Pyrazole derivatives which modulate stearoyl-coa desaturase |
| 01/10/2013 | CA2840883A1 Substituted azaheterocycles for the treatment of cancer |
| 01/10/2013 | CA2838234A1 Oxazepines as ion channel modulators |
| 01/10/2013 | CA2838223A1 Fused benzoxazepinones as ion channel modulators |
| 01/10/2013 | CA2837524A1 Dihydropyrazoles |
| 01/09/2013 | EP2543667A1 2-aminopyridine analogs as glucokinase activators |
| 01/09/2013 | EP2543664A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 01/09/2013 | EP2542549A2 Inhibitors of glutaminyl cyclase |
| 01/09/2013 | EP2542545A1 Inhibitors of hepatitis c virus ns5b polymerase |
| 01/09/2013 | EP2542538A1 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides |
| 01/09/2013 | EP2542537A1 Novel compounds for modulation of orphan nuclear receptor rar-related orphan receptor-gamma (ror gamma, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune disease |
| 01/09/2013 | EP2542536A1 Morpholino substituted urea derivatives as mtor inhibitors |
| 01/09/2013 | EP2542525A1 Cationic 6-aminoindolines, dyeing compositions containing them, processes and uses thereof |
| 01/09/2013 | EP2542524A1 Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 01/09/2013 | EP2542086A1 Compounds and therapeutic uses thereof |
| 01/09/2013 | EP2542077A1 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 01/09/2013 | CN102863434A Synthetic method of nifuratel |
| 01/09/2013 | CN102863388A Tumor targeted drug Combretastatin A4 derivatives |
| 01/09/2013 | CN101910160B Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 01/09/2013 | CN101896482B Novel thiophene derivatives as S1P1/EDG1 agonist |
| 01/09/2013 | CN101711243B 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives |
| 01/09/2013 | CN101573346B Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments |
| 01/09/2013 | CN101400655B Quinolone derivative or pharmaceutically acceptable salt thereof |
| 01/08/2013 | US8350055 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 01/08/2013 | US8350028 2-aminoquinolines |
| 01/08/2013 | US8350027 Dual-acting pyrazole antihypertensive agents |
| 01/08/2013 | US8350026 VEGF-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 01/08/2013 | US8350025 Process for preparing 6-phenoxypyrimidin-4-OL derivatives in the presence of a quinuclidine or a N-methyl pyrrolidine derivatives |
| 01/08/2013 | US8349859 Pyrimidine derivatives |
| 01/08/2013 | US8349833 Compounds, compositions and methods useful for cholesterol mobilisation |
| 01/08/2013 | US8349832 Compounds and compositions for treating cancer |
| 01/08/2013 | US8349830 Aryl aminopyridine PDE10 inhibitors |
| 01/08/2013 | US8349824 Triazolopyridine compounds |
| 01/08/2013 | CA2677315C Pyrimidinylaminobenzamide derivatives and their use as inhibitors of tyrosine kinases |
| 01/08/2013 | CA2630460C Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors |
| 01/08/2013 | CA2582545C Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel |
| 01/08/2013 | CA2567574C Benzotriazine inhibitors of kinases |
| 01/08/2013 | CA2562571C Novel androgens |
| 01/08/2013 | CA2560936C Process for producing 5-hydroxy-4-thiomethylpyrazole compound |
| 01/08/2013 | CA2557372C Diaminopyrimidines as p2x3 and p2x2/3 antagonists |
| 01/08/2013 | CA2478731C Carbamates as hiv protease inhibitors |
| 01/03/2013 | WO2013002357A1 Hiv replication inhibitor |
| 01/03/2013 | WO2013001499A1 Indoleamine derivatives for the treatment of central nervous system diseases |